Introduction
Chronic granulomatous disease results from impaired respiratory burst activity caused by a mutated phagocyte nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase complex. 1 This enzyme complex consists of two membrane spanning subunits (gp91phox and p22phox) plus three cytosolic components (p47phox, p67phox and p40phox). Approximately 60% of all patients with chronic granulomatous disease have been estimated to suffer from mutations in the gp91phox gene with an additional 30% suffering from p47phox gene mutations. 2 The p47phox subunit is a cytoplasmic protein recruited to the transmembrane NADPH-oxidase complex upon respiratory burst induction. At present, a gene therapy (GT) vector for the p47phox-deficient form of chronic granulomatous disease is being developed. Critically, the efficacy of GT should be monitored by the detection of transgenic p47phox expression.
As cellular integrity is an absolute prerequisite for the induction of phagocytic NADPH-oxidase activity, it is impossible to combine functional analyses with the detection of p47phox protein by immunostaining.
To overcome this limitation, we developed a system in which the expression of the cytoplasmic transgene product is linked to, and can be monitored by, the coexpression of a cellular surface marker. A single open reading frame was created encoding the therapeutic p47phox transgene linked to the DLNGFR (truncated low-affinity nerve growth factor receptor) surface marker protein by the Foot and Mouth Disease Virus 2A peptide. In this 2A-mediated coexpression system, the detection of the surface marker provides an indirect measure for the expression of the cytoplasmic transgene product.
Results
The DLNGFR surface marker and the therapeutic p47phox transgene product are synthesized in a 1:1 ratio
The p47phox marker construct was assembled to encode a single, self-processing, polyprotein comprising three domains: (i) an N-terminal domain of DLNGFR (NM_002507; nts. 114-944), (ii) the 2A oligopeptide (31aa; X00871; nts. 3483-3575) and (iii) the C-terminal domain comprising the p47phox subunit of the NADPH-oxidase (M25665, codon optimized) ( Figure 1a ). Cotranslational ribosomal 'skipping' mediated by 2A is predicted to produce two translation products: the transmembrane DLNGFR fused to the 2A peptide ('DLNGFR-2A'), and the cytoplasmic p47phox protein with an N-terminal proline (P-p47phox).
To test this marker system and its influence on the transgenic protein activity, murine 32D hematopoietic progenitor cells (German Collection of Microorganisms and Cell Cultures (DSMZ), DSMZ no.: ACC 411) were transduced using a recombinant gammaretrovirus encoding the marker construct. Transgene expression was confirmed by fluorescence-activated cell sorting (FACS) analysis. Surface staining of 'DLNGFR-2A' and staining of intracellular p47phox demonstrated a transduction rate of 22% in each case. As expected, surface 'DLNGFR-2A' staining plus intracellular p47phox double staining revealed exclusively 'DLNGFR-2A'/P-p47phox doublepositive and double-negative cells, whereas P-p47phox could not be detected by surface staining (Figure 1b) .
To confirm cotranslational 'cleavage,' protein extracts of DLNGFR-2A-p47phox-transduced 32D cells were analyzed by western blotting. P-p47phox linked to 'DLNGFR-2A' showed a very weak band with identical molecular weight in both blots, corresponding to the expected size of the uncleaved polyprotein (Figure 1c , filled triangles). Strong bands were detected for both cleavage products 'DLNGFR-2A' and P-p47phox ( Figure 1c , open triangles), with the DLNGFR-2A translation product migrating slightly faster than the DLNGFR control. Long exposure time revealed the uncleaved fusion protein in addition to the DLNGFR-2A cotranslational cleavage product, both migrating as double bands with the lower molecular mass band predominant (Supplementary Figure S1) . A corresponding double band could not be seen for the P-p47phox cotranslational cleavage product indicating proteolytic processing of DLNGFR, at least in 32D cells.
Signal intensities of both western blots indicate that 498% of the transgene-encoded proteins were synthesized as separated (cleaved) proteins due to ribosome 'skipping' mediated by the 2A sequence.
The DLNGFR surface epitope correlates with the presence of the cytoplasmatic p47phox protein in vivo Lineage-negative bone marrow (linÀ BM) cells from p47phoxÀ/À mice were isolated, gammaretrovirally intensities. In the spleen, granulocytes and monocytes were identified separately by anti-Ly-6G/Ly-6C (mAb RB6-8C5) and anti-Ly-6G (mAB 1A8) double staining. Granulocytes (RB6-8C5+/1A8+) varied in DLNGFR staining intensity. In splenic monocytes (RB6-8C5+/ 1A8-), however, the intracellular p47phox signal ran in parallel to the surface DLNGFR staining. The same parallel between the p47phox and DLNGFR signals were observed within a hematopoietic stem and progenitorenriched population of sca-I+ BM cells, in splenic B220+ B and in CD3+ T cells. Taken together, with the exception of granulocytes, the intracellular p47phox FACS signal ran in parallel to the DLNGFR surface marking in non-DLNGFR/p47phox double-negative cells.
The P-p47phox translational-skipping product restores respiratory burst activity in vitro and in vivo
We next investigated whether the P-p47phox translational skipping product was able to restore respiratory burst activity. The DLNGFR-2A-p47phox retrovirus vector was used to transduce linÀ BM cells obtained from p47phoxÀ/À mice and subsequently differentiated to granulocytes ex vivo. Granulocytes derived from untransduced and transduced p47phoxÀ/À linÀ BM cells were stimulated with phorbol myristate acetate and the NADPH-oxidase activities visualized by a nitroblue tetrazolium assay. Within the transduced cell population, the reduction of nitroblue tetrazolium to its formazan derivative in individual cells yielded intracellular blue/black precipitates, demonstrating restoration of the NADPH-oxidase activity (Figure 3b )-not observed in the negative-control (Figure 3a) . Six weeks after reinfusion of transduced linÀ BM cells into p47À/À mice, blood samples were analyzed for respiratory burst activity. Mouse blood was stained with the Ly-6G/Ly-6C-specific mAb clone RB6-8C5. Ly-6G/Ly-6C-positive cells were analyzed for DLNGFR expression and their respiratory burst activity upon phorbol myristate acetate stimulation was determined by the FACS-based dihydrorhodamin-123 (DHR) oxidation assay. As expected, unstimulated Ly-6G/Ly-6C+ blood cells were partially DLNGFR-positive and DHRnegative (Figure 3c ). Upon stimulation, the shift in DHR signal demonstrates activation of the NADPH-oxidase and reconstitution of respiratory burst activity in neutrophils and monocytes derived from transduced stem cells in vivo (Figure 3d ). Those Ly-6G/DLNGFRpositive cells that do not show a shift in DHR signal are expected not to represent monocytes or granulocytes, as the anti-Ly-6G/Ly-6C mAb clone RB6-8C5 also detects Ly-6C-positive dendritic cells and sub-populations of lymphocytes 4 with no respiratory burst activity. Recently, it has been reported that gammaretroviral transduction of macrophages is possible, although with low efficiency. 5 Therefore, we analyzed the activity of the construct in human macrophages derived from a patient with p47phox-chronic granulomatous disease (Figures 3e,f and g ). Monocytes were isolated and differentiated into macrophages for 7 days. Macrophages were then transduced, and analyzed for NADPHoxidase activity 3 days later. As expected, 5 transduction efficiency was low. As in the murine model, we detected nitroblue tetrazolium-positive cells in transduced human cells. This clearly indicates that the cytoplasmic P-p47phox translational skipping product is able to restore the NADPH-oxidase activity not only in primary murine cells (both ex vivo and in vivo) but also in transduced cells derived from the primary human cells.
Discussion
The 2A coexpression methodology was applied to overcome the limitation that detection of the cytoplasmic although N-terminal extensions increase the activity up to 499% for 2A sequences of 33aa or longer. [7] [8] [9] The cleavage efficiency of the present construct containing 31aa of 2A is consistent with efficiencies previously reported. Owing to the high cleavage efficiency of our marker system, the detection of the 'DLNGFR-2A' surface marker provides a direct measure for the presence of the cytoplasmic p47phox transgene product. Moreover, the cleavage process of a translation product encoded in a single open reading frame dictates a 1:1 ratio of the two cleavage products. Our mouse experiments showed that position-effect variegation ran in parallel for the therapeutic protein product (intracellular p47phox) and the cell surface marker (DLNGFR) in hematopoietic stem/progenitor cells, monocytes, T cells and B cells. Surprisingly, the intracellular p47phox/surface DLNGFR double staining revealed individual populations in granulocytes differing in DLNGFR-staining intensities. The explanation for this observation is unclear and a detailed analysis is ongoing.
The use of intracellular ribosomal entry sites (IRES) represents an alternative approach to generate multicistronic expression from one vector. In a bicistronic IRES-based vector, translation initiation of the 5 0 coding reading frame requires the m 7 G cap and its associated protein factors, whereas the 3 0 encoded reading frame is thought to be translated cap-independently by direct recruitment of the ribosome to the IRES element. Owing to different efficiencies of translation initiation, the open reading frame downstream of IRES is consistently less expressed than the open reading frame upstream of IRES. 10 Compared with IRES-based biscistronic expression, GFP coexpression by the 2A strategy was approximately four times higher.
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In addition, the packaging capacity is limited in retroviral vectors. 12 Regarding size limitations, the 19AA/57nt 2A sequence is advantageous compared to, for example, 470nt IRES of foot and mouth disease virus or the 640nt IRES of Poliovirus. Furthermore, both IRES sequences were reported to result in retroviral titer reduction, whereas 2A did not. 13 One reason for this reduction in retroviral titers by IRES sequences might be their secondary structure. The hepatitis C virus-like picornavirus IRES elements are known to possess extensive RNA secondary structure identified as substrate for the Dicer ribonuclease. 14 A ribonucleolytic cleavage by Dicer would interfere with the retroviral life cycle.
In our vector, DLNGFR serves as a membraneexpressed marker epitope indirectly representing the cytoplasmic P-p47phox translation product. The DLNGFR marker protein was used previously until Li and et al. 15 reported one leukemic transformation event in a single mouse by a DLNGFR containing gammaretroviral long terminal repeat-driven (non-selfinactivating) vector after integration into the murine Evi1 gene associated with Evi1 expression. However, data amassed from 17 independent investigators from 4300 mice having received BM transplantation of hematopoietic stem cells transduced with DLNGFR expressing retroviral vectors revealed no adverse events. This weakens the argument for an increased frequency of insertional oncogenesis by DLNGFR.
16 Malignant transformation is a multistep process, 17 in which retroviral insertion may be just one event.
18 Evi1 overexpression resulting from retroviral insertion near Evi1 has been reported to interact with mutant AML1 to induce myelodysplastic syndrome/acute myeloid leukemia. 19 Interestingly, DLNGFR had been used in two clinical trials as marker molecule for the gammaretroviral transduction of patient T cells (mentioned in the study by Recchia et al. 20 ). Cumulatively, the 46 patients treated since 1994 received a total of 410 11 genetically modified T cells. Expansion (up to 40% of circulating cells) and long-term persistence (410 years) of transduced T cells were observed in these patients in the absence of any adverse event or toxic effect related to the gene transfer procedure. A detailed follow-up of two patients after 10 years revealed that despite the observed frequency of insertional gene activation, there was no evidence of clonal selection or preferential survival of transduced T cells. 20 These facts lead to the conclusion that the leukemia was induced in Li's mouse 15 by vector long terminal repeat-mediated Evi1 overexpression only in combination with an undetected preexisting or acquired additional hit, but not by DLNGFR alone. DLNGFR thus represents a useful marker protein not only for preclinical gene transfer studies involving therapeutic cytoplasmic proteins but might potentially also be applied in future clinical GT using retroviral selfinactivating vectors. Nevertheless, the presented cloning strategy is not limited to DLNGFR. The 2A methodology can be adapted to other transmembrane marker proteins under maintenance of the 1:1 ratio of synthesized therapeutic protein and marker protein. After cotranslational ribosomal 'skipping,' the cytoplasmic skipping product consisted of the therapeutic p47phox transgene product N terminally prolonged by one proline (P-p47phox). We have shown by functional assays that the biological activity of p47phox is not affected by the addition of an N-terminal proline residue derived from the 2A sequence combining DLNGFR and p47phox.
In summary, the presented cytoplasmic/surface marker coexpression technology allows highly efficient, indirect detection of cytoplasmic transgene products by FACS surface staining. The cloning strategy can be easily Surface detection of cytoplasmic proteins V Wohlgensinger et al adapted to different cytoplasmic therapeutic transgene products and alternative surface marker proteins, and it provides a useful tool for the detection of cytoplasmic transgene products optionally applied for GT monitoring.
Materials and methods

Vectors
The gammaretroviral vector backbone was derived from self-inactivating gammaretroviral SERS11.SF.gp91.W (gift of M Grez). The transgene was exchanged against a cassette containing the N-terminal domain of DLNGFR (NM_002507; nts. 114-944), the 2A oligopeptide (31aa; X00871; nts. 3483-3575) followed by the p47phox subunit of the NADHP-oxidase (M25665, codon optimized).
Virus production and transduction
For retroviral vector production, PhoenixE cells or 293T cells were co-transfected with the DLNGFR-2A-p47phox gammaretroviral self-inactivating vector together with pUMVC plus pMD2.VSV.G or M187 (gift of M Grez) in the presence of 10 mM chloroquin (Sigma-Aldrich, Buchs, Switzerland). Cell-free virus supernatant was concentrated using Amicon-15 centrifugal filter devices with 100 000 kDa cutoff (Millipore, Volketswil, Switzerland).
For transduction of 32D cells, the viral particles and 10 5 cells were spinoculated for 90 min, 400 g at 32 1C with 8 mg ml À1 protamine sulfate (Sigma-Aldrich) and incubated overnight. For transduction of mouse linÀ BM cells, the viral particles were spinoculated (400 g, 30 min, 4 1C) onto fibronectin-coated tissue culture plates. The linÀ BM cells were prestimulated for 2 days, spun down onto the virus preloaded plates 21 and kept in culture for 3 days.
For transduction of human monocyte-derived macrophages, monocytes were isolated from the human whole blood using CD14 microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany), allowed to settle for 3 h and cultured in RPMI, 10% fetal calf serum, 1 mM granulocytemacrophage-colony-stimulating factor for 7 days. Then, viral particles were spinoculated onto the adherent macrophages (90 min, 400 g at 32 1C).
5
Antibodies
Fluorescein isothiocyanate-anti-LNGFR (cloneME20.4-1.H4) and fluorescein isothiocyanate anti-CD3e (clone145-2C11) were from Miltenyi Biotec. Phycoerythrin anti-LNGFR (clone C40-1457), fluorescein isothiocyanate anti-Ly-6G (1A8), PerCP-Cy5.5 anti-Ly-6G and Ly-6C (clone RB6-8C5), phycoerythrin anti-Ly-6A/E Sca-I (E13-161.7) and fluorescein isothiocyanate anti-CD45R/B220 (clone RA3-6B2) were from BD Biosciences (Allschwil, Switzerland), as was anti-p47phox antibody (clone 1) which was APC-labeled by BD-services.
Murine cells were first blocked with Fc block anti-CD16/CD32 (clone 2.4G2, BD Biosciences). For combined surface/intracellular staining, cells were incubated with surface antibody for 1 h, washed twice, followed by intracellular staining with anti-p47phox-APC using the Cytofix/Cytoperm Kit (BD Biosciences) according to the manufacturer's instructions. Flow cytometry analyses were performed with FACS Calibur (BD Biosciences).
Western blot analyses were performed using ECL Advanced Western Blot Detection Kits (GE Healthcare).
Mice p47phoxÀ/À mice (B6(Cg)-Ncf1m1J/J) were obtained from the Jackson Laboratory (Bar Harbor, ME, USA). Mice were maintained under specific pathogen-free conditions. Housing and experimental protocols were in accordance with the Swiss animal protection law and in compliance with the regulations of the Veterinaeramt, Kanton Zurich. For isolation of linÀ BM cells, BM was harvested from femurs/tibias and enriched by the 'Lineage Cell Depletion Kit' (Miltenyi Biotec).
For BM transplantation, 4-to 6-week-old mice were irradiated with 950 cGy. Per mouse, 1E6 gammaretrovirally transduced linÀ BM cells were injected 4 h later by tail vein injection. Mice received prophylactic neomycin (Sigma-Aldrich) as additive in drinking water (1.67 mg ml
À1
). For ex vivo granulocyte differentiation, linÀ BM cells were washed 2 days after transduction and cultured in RPMI, 20% fetal calf serum, 100 ng ml À1 granulocyte-colony-stimulating factor and 10 ng ml À1 interleukin-3 for 12 days.
Functional assays
The nitroblue tetrazolium assay and dihydrorhodamine assay DHR123 were carried out as described 22 with one modification: To identify murine granulocytes/monocytes in the DHR123 assay, we first stained the blood samples using mAB clone RB6-8C5 and conducted the assay with the prestained samples. FACS analysis was carried out on a FACS Calibur (BD Biosciences) and images were captured by a Leica DM IL HC microscope (Leica Microsystems, Heerbrugg, Switzerland).
